← SynDRA
TOLTERODINE
SynDRA canonical compound SYN0005886 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Approval status | Approved · Rx/OTC |
| Primary target(s) | CHRM4 |
| Mechanism of action | Acetylcholine receptor antagonist |
| Indication | urinary frequency | urinary incontinence |
| Disease area | urology |
All known targets
- CHRM3
- CHRM2
- CHRM1
- CHRM4
- CHRM5
- Chrm1
- Chrm2
- Chrm3
- Chrm4
- Chrm5
- KCNH2
Mechanisms of action (all sources)
- Acetylcholine receptor antagonist
- CHRM3 ANTAGONIST
- Muscarinic acetylcholine receptor M3 antagonist
- CHRM2 ANTAGONIST
- Muscarinic acetylcholine receptor M2 antagonist
Drug classes
- Cholinergic Muscarinic Antagonists
- Cholinergic Agents
- Cholinergic Antagonists
- Muscarinic Antagonists
- Neurotransmitter Agents
- Urological Agents
- Cholinergic Muscarinic Antagonist
ATC classes
Cross-references
Synonyms
- tolterodine tartrate
- (+)-Tolterodine
- (R)-Tolterodine
- Tolterodina
- KABI-2234
- Blerone xl
- Detrusitol
- Detrusitol xl
- Efflosomyl xl
- Inconex xl
- Mariosea xl
- Neditol xl
- Preblacon xl
- Santizor xl
- Tolterodinum
- Detrol (TN)
- Detrusitol (TN)
- Kabi-2234
- 2-[(1R)-3-(diisopropylamino)-1-phenylpropyl]-4-methylphenol
- 2-[(1R)-3-[di(propan-2-yl)amino]-1-phenylpropyl]-4-methylphenol
- 2-[3-[Bis(1-methylethyl)amino]-1-phenylpropyl]-4-methylphenol
- 2-{(1R)-3-[bis(1-methylethyl)amino]-1-phenylpropyl}-4-methylphenol
- WHE7A56U7K
- (+)-(R)-2-(alpha-(2-(Diisopropylamino)ethyl)benzyl)-p-cresol
- CHEBI:9622
- RefChem:56377
- G04BD07
- (R)-(+)-Tolterodine
- Tolterodine [INN]
- R-(+)-Tolterodine
- Tolterodinum [INN-Latin]
- Tolterodina [INN-Spanish]
- Urotrol
- (r)-2-(3-(diisopropylamino)-1-phenylpropyl)-4-methylphenol
- NCGC00159519-02
- tolterodin
- DTXCID703687
- Unidet
Reported adverse events
- Dry mouth
- Dry skin
- Dyspepsia
- Dysuria
- Fatigue
- Headache
- Vertigo
- Arthralgia
- Chest pain
- Constipation
- Influenza
- Somnolence
Look up TOLTERODINE in the interactive SynDRA portal →